EUVIMEDEUVIMED entdecken
Crossref

Linezolid-Induced Serotonin Release from QGP-1 Cells

Takezo Tsutsumi iD, Hitoshi Kashiwagi, Shungo Imai, Yuki Sato, Shunsuke Nashimoto, Mitsuru Sugawara, Yoh Takekuma

Drug Research · 01.07.2026 · 76 (04/06) · 125-130

DOI: 10.1055/a-2815-4097 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Research, erschienen am 01.07.2026. Verfasst von Takezo Tsutsumi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Pharmacy, Hokkaido University Graduate School of Life Science, Sapporo, Japan. Hauptthemen laut MEDLINE: Linezolid, Serotonin, Enterochromaffin Cells.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Nausea and vomiting are commonly reported side effects of long-term linezolid therapy, which is indispensable for tuberculosis and osteoarticular infections. Since the mechanism underlying the development of nausea and vomiting during linezolid treatment is unknown, this study aimed to explore the mechanisms by focusing on the monoamine oxidase-inhibiting effect of linezolid.

Methods

In vitro serotonin release assays were performed using QGP-1 cells as a surrogate for enterochromaffin cells exposed to linezolid, the monoamine oxidase inhibitor clorgyline, and the known emetogenic agent cisplatin. Serotonin concentrations in the solutions were measured using an enzyme-linked immunosorbent assay. Clorgyline and cisplatin were administered simultaneously with linezolid to elucidate the serotonin release mechanism and confirm the synergistic effects. The intracellular Ca2+assays using Fura‑2 were also performed to assess whether serotonin release is mediated by Ca2+‑dependent exocytosis.

Results

Linezolid exposure significantly increased serotonin release from QGP-1 cells in concentration- and time-dependent manners. Serotonin release also increased in the clorgyline exposure group, and the release of serotonin in the linezolid/clorgyline co-exposure group was higher than that in the single-exposure groups. In contrast, no significant serotonin release or synergistic effects were observed in the cisplatin/linezolid-exposed groups. The Ca2+assays demonstrated that linezolid exposure did not change intracellular Ca2+levels.

Conclusions

Serotonin release was observed when QGP-1 cells were exposed to linezolid, an effect similar to that observed with the potent monoamine oxidase A inhibitor clorgyline. Furthermore, the Ca2+assays indicated that linezolid‑induced serotonin release occurs independently of Ca2+‑dependent exocytosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LinezolidSerotoninEnterochromaffin CellsAnimalsCalciumCell LineMonoamine Oxidase InhibitorsClorgylineCisplatinExocytosisHumans

Substanzen

LinezolidSerotoninCalciumMonoamine Oxidase InhibitorsClorgylineCisplatin

Autor:innen und Institutionen

  • Division of Clinical Pharmacy, Hokkaido University Graduate School of Life Science, Sapporo, Japan.
  • Pharmacy, Hokkaido University Hospital, Sapporo, Japan.
  • Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
  • Faculty of Pharmacy, Keio University, Minato-ku, Japan.

ORCID-Profile: Takezo Tsutsumi

Zitieren

APA

Tsutsumi, T., Kashiwagi, H., Imai, S., Sato, Y., Nashimoto, S., Sugawara, M., & Takekuma, Y. (2026). Linezolid-Induced Serotonin Release from QGP-1 Cells. Drug Research, 76(04/06), 125-130. https://doi.org/10.1055/a-2815-4097

Vancouver

Tsutsumi T, Kashiwagi H, Imai S, Sato Y, Nashimoto S, Sugawara M, et al. Linezolid-Induced Serotonin Release from QGP-1 Cells. Drug Research. 2026;76(04/06):125-130. doi:10.1055/a-2815-4097

BibTeX
@article{Tsutsumi2026,
  author = {Tsutsumi, Takezo and Kashiwagi, Hitoshi and Imai, Shungo and Sato, Yuki and Nashimoto, Shunsuke and Sugawara, Mitsuru and Takekuma, Yoh},
  title = {Linezolid-Induced Serotonin Release from QGP-1 Cells},
  journal = {Drug Research},
  year = {2026},
  volume = {76},
  number = {04/06},
  pages = {125--130},
  doi = {10.1055/a-2815-4097}
}
Kostenlos starten →